FindTrial
Sign In

An observational study on QT interval changes with Hydroxychloroquine used as prophylaxis in COVID exposure risk individuals

An observational study on Hydroxychloroquine used as prophylaxis for high COVID exposure risk individuals with special reference to QT interval

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/05/025289
Enrollment
50
Registered
2020-05-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil

Sponsors

P Vamsavardhana Reddy
Lead Sponsor
Anupam Bhambani
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: All High COVID exposure risk individuals aged above 18 years & weight > 35 kg consuming Hydroxychloroquine as prophylaxis for COVID-19

Exclusion criteria

Exclusion criteria: Individuals not willing to participate in the study

Design outcomes

Primary

MeasureTime frame
Magnitude and frequency of QTc changes. Timepoint: At 8 weeks—

Secondary

MeasureTime frame
1)Time interval to develop QTc prolongation after HCQ intake. 2)Other short term adverse drug reactions (ADRs) â?? serious/ Nonserious. Timepoint: At 8 weeks—

Countries

India

Contacts

Public ContactP Vamsavardhana Reddy

Vydehi Institute of Medical Sciences and Research Centre

vamsareddy4403@vimsmail.com9686316728

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026